Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1154-1165
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1154
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1154
Initial | Upgrade | Indications | Advantages | Disadvantages | Results |
EMR | EMR | Tumors confined to the mucosa, without vascular and lymphatic metastatic foci | Simple operation and short operation time | Incomplete resection (tumor diameters ≥ 2 cm) | The rate of local recurrence was 2%-35% after the operation[5] |
BA-EMR | SMT (< 1.2 cm)[6] | Simplify the treatment procedure, shorten the duration of the procedure, hospitalization and reduce complications | Not mentioned | Safe and effective | |
EMR-P | Small gastric adenomas (≤ 15 mm in diameter) | Shorter operative time than ESD | Less effective in proximal gastric adenomas[7] | Effective | |
mEMR-C | Small (≤ 20 mm) intraluminal gGISTs | Shorter operative time and lower cost than ESD | Not mentioned | A new variant of standard EMR | |
UEMR | UEMR | The resection of esophageal, gastric, duodenum, ampullary, small intestinal and colorectal lesions[10] | Obtain sufficient submucosal tissue without needle injection to provide accurate pathologic diagnosis | Not mentioned | Feasible, safe and effective |
ESD | ESD | Gastrointestinal tumors; the elderly patients[20] | Expands the scope of lesion resection and improves overall lesion resection; reduce serum CA125 levels, regulate PG secretion | Its intraoperative procedures are more complex and time-consuming than EMR[22]; the incidence of intraoperative bleeding in ESD is significantly higher than that in EMR | Reduces the risk of local recurrence[18], provides complete pathological data and accurate pathological evaluation[19]; promote the recovery of gastric gland function[21] |
EFTR | EFTR | Gastrointestinal subepithelial tumors with malignant potential SET[27] | Allows minimal resection of the gastric wall; facilitate postoperative recovery | Carry a risk of peritoneal infection or dissemination | Safe and reliable |
EFTR-L | Small gastric SET (≤ 1.5 cm) originating from the intrinsic muscularis propria | A shorter operative time and lower cost than EFTR[28] | Not mentioned | Efficacy | |
OTSC-assisted EFTR | Gastrointestinal stromal tumors | Especially suit for gastrointestinal stromal tumors < 20 mm in size[29] | Not mentioned | Safely and effectively resected | |
Clip-and snare-assisted EFTR | MP-GISTs | Provide unique endoscopic visualization, adequate exposure of the cutting line and sufficient maneuvering space[30] | Not mentioned | Safe and effective | |
EFTR-C | GIST | The treatment outcome, AEs, hospital stay and postoperative recovery of patients with GIST were better than those in the group of EFTR | Not mentioned | The first choice for small (≤ 1.5 cm) gastric GIST | |
NT-EFTR | GISTs | No-touch | Large tumors with extraluminal growth and large gastric defects impact procedural difficulty | A feasible method | |
NESS-EFTR | EGC | Prevent tumors from being exposed to the peritoneal cavity | Not mentioned | NESS-EFTR combined with sentinel pelvic dissection for EGC results in safe margins and prevents intraoperative perforation | |
TAMIC | The closure of large perforations after gastric EFTR | Twin-grasper assisted mucosal inverted closure technique[36] | Tumor size ≥ 3 cm and the position of gastric body are the risk factors for the treatment | Safe and novel | |
TT method adjunctive to EFTR | Gastric SMT | Effectively shorten the operative time and reduce the risk of complications[38] | Not mentioned | Effective | |
Eo-EFTR | Deep gastric submucosal tumors | High complete resection rates and low surgical conversion rates | Not mentioned | Relatively safe | |
DFC assist with traction | When EFTR treatment for SMT has limitations in the gastric fundus | Relieve tumor borders, simplify the procedure and shorten the procedure time, and reduce the risk of post-EFTR electrocoagulation syndrome[40,41] | Not mentioned | Decipher the limitations, increase the effectiveness of EFTR | |
The modified method named ZIP | SMT smaller than 2.5 cm | The mucosal layer of gastric wall defects after EFTR can be effectively closed | Not mentioned | Achieve the goal of successful closure of gastric wall defects | |
Third-space EFTR | Small gastric submucosal tumors | Involves multiple procedures[43] | Not mentioned | Feasible and safe | |
"Shao-Mai" closure method | The defect closure after EFTR for gastric SMT in the gastric wall | An endo-loop was anchored onto the edge of the gastric defect with grasping forceps assistance and closed tightly | Not mentioned | A novel and simplified closure method[44] | |
ESE | ESE | Gastric lesions in the intrinsic muscular layer | More extensive, earlier postoperative feedings, shorter postoperative hospital stays, and lower hospitalization costs compared with EFTR[49] (gastric SETs < 3 cm) | Not suitable for deeper lesions | Safe and effective |
STER | STER | Resect SMT located in the esophagus and cardia, both cardia and non-cardia gastric SMT; obese patients | A low incidence of complications and can be conservatively treated when encountering complications | It is more difficult to perform a STER in the stomach than in the esophagus | Easible |
LECS | LECS | Gastric SMT with ulcerative lesions and early stage T1a GC[63,64] | Minimal intraoperative bleeding, reasonable surgical time and good postoperative outcomes | Not mentioned | Ideal for the treatment of G-GIST up to 5 cm |
- Citation: Li CY, Wang YF, Luo LK, Yang XJ. Present situation of minimally invasive surgical treatment for early gastric cancer. World J Gastrointest Oncol 2024; 16(4): 1154-1165
- URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1154.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1154